Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Antiviral prophylaxis for varicella zoster in immunocompromised patients (excluding haematological malignancies)

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD008052Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 07 October 2009see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Acute Respiratory Infections Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Christina C Chang

    Correspondence to: Infectious Diseases Unit, The Alfred Hospital, Monash University, Prahran, Australia

    [email protected]

    [email protected]

  • Allen C Cheng

    Department of Epidemiology and Preventive Medicine, Monash University, 2nd Floor, Burnet Centre, Alfred Hospital, Melbourne, Australia

  • Richard J Maude

    Mahidol‐Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

  • Monica Slavin

    Peter MacCallum Cancer Institute, East Melbourne, Australia

Contributions of authors

All authors contributed to the writing of the protocol.

Declarations of interest

All authors: none declared.

Acknowledgements

The review authors thank Liz Dooley for her editorial assistance. We also acknowledge Max Bulsara, Per Ljungman, David Weinstock, Marian Nicholson, and Diederik van de Beek for their kind review of our protocol.

Version history

Published

Title

Stage

Authors

Version

2015 Jul 01

Antiviral prophylaxis for varicella zoster in immunocompromised patients (excluding haematological malignancies)

Protocol

Christina C Chang, Allen C Cheng, Richard J Maude, Monica Slavin

https://doi.org/10.1002/14651858.CD008052.pub2

2009 Oct 07

Antiviral prophylaxis for varicella zoster in immunocompromised patients (excluding haematological malignancies)

Protocol

Christina C Chang, Allen C Cheng, Richard J Maude, Monica Slavin

https://doi.org/10.1002/14651858.CD008052